tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ABBV Stock Latest News

3 Best Stocks to Buy Now, 11/19/2024, According to Top Analysts 
Market News3 Best Stocks to Buy Now, 11/19/2024, According to Top Analysts 
2d ago
ABBV
ATEC
AbbVie receives EC approval of Elahere
PremiumThe Fly
AbbVie receives EC approval of Elahere
3d ago
ABBV
Wolfe starts AbbVie at Outperform, says valuation an attractive entry point
PremiumThe Fly
Wolfe starts AbbVie at Outperform, says valuation an attractive entry point
7d ago
ABBV
AbbVie initiated with an Outperform at Wolfe Research
PremiumThe Fly
AbbVie initiated with an Outperform at Wolfe Research
7d ago
ABBV
JPMorgan trims AbbVie target, removes from Analyst Focus List
PremiumThe Fly
JPMorgan trims AbbVie target, removes from Analyst Focus List
8d ago
ABBV
Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
PremiumThe FlyElliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
9d ago
S
HD
Bristol Myers price target raised to $61 from $57 at BMO Capital
Premium
The Fly
Bristol Myers price target raised to $61 from $57 at BMO Capital
9d ago
BMY
ABBV
Nvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls
9d ago
S
ON
AbbVie price target lowered to $208 from $228 at BMO Capital
PremiumThe Fly
AbbVie price target lowered to $208 from $228 at BMO Capital
9d ago
ABBV
Bristol Myers price target raised to $39 from $36 at Morgan Stanley
PremiumThe Fly
Bristol Myers price target raised to $39 from $36 at Morgan Stanley
9d ago
BMY
ABBV
AbbVie price target lowered to $224 from $231 at Morgan Stanley
PremiumThe Fly
AbbVie price target lowered to $224 from $231 at Morgan Stanley
9d ago
BMY
ABBV
Leerink upgrades Bristol to Outperform after AbbVie schizophrenia failure
PremiumThe Fly
Leerink upgrades Bristol to Outperform after AbbVie schizophrenia failure
9d ago
BMY
ABBV
AbbVie price target lowered to $215 from $226 at Citi
PremiumThe FlyAbbVie price target lowered to $215 from $226 at Citi
9d ago
ABBV
Cigna drops pursuit of Humana: Morning Buzz
Premium
The Fly
Cigna drops pursuit of Humana: Morning Buzz
10d ago
CE
CI
Evercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive
Premium
The Fly
Evercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive
10d ago
BMY
ABBV
AbbVie under pressure as schizophrenia drug fails two trials
PremiumThe Fly
AbbVie under pressure as schizophrenia drug fails two trials
10d ago
BMY
ABBV
Leerink sees AbbVie’s trial results as ‘clear positive’ for Bristol Myers
PremiumThe Fly
Leerink sees AbbVie’s trial results as ‘clear positive’ for Bristol Myers
10d ago
BMY
ABBV
Barclays still likes AbbVie into 2025 despite schizophrenia failures
PremiumThe Fly
Barclays still likes AbbVie into 2025 despite schizophrenia failures
10d ago
ABBV
JPMorgan sees AbbVie off about 10%, Bristol up 10%-15% on emraclidine news
PremiumThe Fly
JPMorgan sees AbbVie off about 10%, Bristol up 10%-15% on emraclidine news
10d ago
BMY
ABBV
AbbVie falls -12.2%
PremiumThe FlyAbbVie falls -12.2%
10d ago
ABBV
AbbVie ‘pain’ is Bristol Myers ‘gain’ after emraclidine fails, says Truist
Premium
The Fly
AbbVie ‘pain’ is Bristol Myers ‘gain’ after emraclidine fails, says Truist
10d ago
BMY
ABBV
AbbVie falls -11.1%
Premium
The Fly
AbbVie falls -11.1%
10d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >